Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.27 USD | -3.70% | -3.70% | +7.41% |
05-08 | UBS raises Centrica to 'buy' from 'neutral | AN |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.94B 389B | Sales 2025 * | 4.27B 5.42B 427B | Capitalization | 3.9B 4.95B 390B |
---|---|---|---|---|---|
Net income 2024 * | 467M 593M 46.7B | Net income 2025 * | 501M 636M 50.1B | EV / Sales 2024 * | 1.13 x |
Net Debt 2024 * | 513M 651M 51.3B | Net Debt 2025 * | 513M 651M 51.3B | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
8.33
x | P/E ratio 2025 * |
7.65
x | Employees | 3,000 |
Yield 2024 * |
2.83% | Yield 2025 * |
3.14% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
1 day | -3.70% | ||
1 week | -3.70% | ||
Current month | -10.35% | ||
1 month | -5.28% | ||
3 months | +7.61% | ||
6 months | +20.45% | ||
Current year | +7.41% |
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 21/04/16 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 11/05/22 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 28/02/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 15/11/17 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 19/05/15 |
Colin Keogh
BRD | Director/Board Member | 69 | 18/11/15 |
Date | Price | Change | Volume |
---|---|---|---|
24/05/24 | 29.27 | -3.70% | 1,030 |
Delayed Quote OTC Markets, May 24, 2024 at 02:32 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.91% | 67.02B | |
+14.49% | 51.34B | |
+10.28% | 48.17B | |
+16.80% | 43.46B | |
+36.60% | 38.24B | |
+79.37% | 33.75B | |
+8.96% | 29.43B | |
+1.72% | 22.12B | |
+12.56% | 20.85B |
- Stock Market
- Equities
- HSX Stock
- HCXLY Stock